Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 283-029-3 | CAS number: 84522-34-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From 2017-04-13 to 2017-04-26
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 2015
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- other: Direct Peptide Reactivity Assay (DPRA)
Test material
- Reference substance name:
- Sodium 5-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazinecarboxamidate
- EC Number:
- 283-029-3
- EC Name:
- Sodium 5-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazinecarboxamidate
- Cas Number:
- 84522-34-9
- Molecular formula:
- C14H16N4NaO3S
- IUPAC Name:
- 5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide;sodium
Constituent 1
- Specific details on test material used for the study:
- Batch: 16024R046
Purity: 100.3%
In chemico test system
- Details on the study design:
- Test system
- Test system: Synthetic peptides containing cysteine (SPCC) or synthetic peptides containing lysine (SPCL).
- Rationale: Recommended test system in the international OECD guideline for DPRA studies.
- Source: JPT Peptide Technologies GmbH
Experimental Design
- Test Item Preparation: 52.96 mg of test item was pre-weighed into a clean amber glass vial and dissolved, just before use, in 1542 μL MQ/ACN (1:1, v/v), to obtain a 100 mM solution.
- Preparation of Solutions for Cysteine Reactivity Assay:
Synthetic Peptide Containing Cysteine (SPCC) Stock Solution: A stock solution of 0.667 mM SPCC (0.501 mg SPCC/mL) was prepared by dissolving 10 mg of SPCC in 19.96 mL phosphate buffer pH 7.5. The mixture was stirred for 5 minutes followed by 5 minutes sonication.
SPCC Reference Control Solutions: Three 0.5 mM SPCC reference control (RC) solutions (RCcysA, RCcysB and RCcysC) were prepared in amber vials by mixing 750 μL of the 0.667 mM SPCC stock solution with 250 μL ACN.
- Preparation of Solutions for Lysine Reactivity Assay:
Synthetic Peptide Containing Lysine (SPCL) Stock Solution: A stock solution of 0.667 mM SPCL (0.518 mg SPCL/mL) was prepared by dissolving 10 mg of SPCL in 19.31 mL of ammonium acetate buffer pH 10.2 followed by stirring for 5 minutes.
SPCL Reference Control Solutions: Three 0.5 mM SPCL reference control (RC) solutions (RClysA, RClysB and RClysC) were prepared in amber vials by mixing 750 μL of the 0.667 mM SPCL stock solution with 250 μL ACN.
- Sample Incubations: After preparation, the samples (reference controls, calibration solutions, co-elution control, positive controls and test item samples) were placed in the autosampler in the dark and incubated at 25±2.5°C. The incubation time between placement of the samples in the autosampler and analysis of the first RCcysB- or RClysB-sample was 26 and 27 hours, respectively. The time between the first RCcysB- or RClysB-injection and the last injection of a cysteine or lysine sequence, respectively, did not exceed 30 hours.
- HPLC-PDA Analysis: SPCC and SPCL peak areas in the samples were measured by HPLC-PDA.
- Other measurement: Prior to HPLC-PDA analysis the samples were visually inspected for precipitation.
Results and discussion
- Positive control results:
- The mean Percent SPCC Depletion for the positive control cinnamic aldehyde was 73.6% ± 0.4%. This was within the acceptance range of 60.8% to 100% with a SD that was below the maximum (SD<14.9%).
The mean Percent SPCL Depletion for the positive control cinnamic aldehyde was 58.3% ±3.3%.. This was within the acceptance range of 40.2% to 69.0% with a SD that was below the maximum (SD<11.6%).
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: Cysteine Reactivity Assay
- Parameter:
- other: SPCC depletion%
- Positive controls validity:
- valid
- Remarks on result:
- other: The test item clearly co-eluted with SPCC and calculation of the peptide depletion was not possible.
- Key result
- Run / experiment:
- other: Lysine Reactivity Assay
- Parameter:
- other: SPCL depletion%
- Value:
- 6.5
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- - Precipitation: Cysteine Reactivity Assay: Upon preparation no precipitate was observed in any of the test item samples. However, after incubation a precipitate was observed in the co-elution control (CC) and test item samples; Lysine Reactivity Assay: Upon preparation and after incubation, both the CC as well as the test item samples were visually inspected.
- Test Acceptability: all acceptability criteria were met this DPRA is considered to be valid.
Any other information on results incl. tables
In the cysteine reactivity assay the test item clearly co-eluted with SPCC and calculation of the peptide depletion was not possible. In the lysine reactivity assay the test item showed 6.5% SPCL depletion. However, after incubation precipitation of the test item was observed. Consequently, SPCL depletion may be underestimated. Since no DPRA prediction and reactivity classification can be made based on SPCL data alone, the DPRA results obtained for test item are inconclusive.
Applicant's summary and conclusion
- Interpretation of results:
- other: The DPRA results for test item are inconclusive.
- Conclusions:
- The DPRA results obtained for test item are inconclusive.
- Executive summary:
The reactivity of test item towards model synthetic peptides containing either cysteine (SPCC) or lysine(SPCL) was determined according to OECD guideline 442C.
After incubation of test item with either SPCC or SPCL, the relative peptide concentration was determined by High-Performance Liquid Chromatography (HPLC) with gradient elution andphotodiodearray (PDA) detection at 220 nm and 258 nm. SPCC and SPCL Percent Depletion Values werecalculated and used in a prediction model which allows assigning the test chemical to one of four reactivity classes used to support the discrimination between sensitizers and non-sensitizers.
In the cysteine reactivity assay the test item clearly co-eluted with SPCC and calculation of the peptide depletion was not possible. In the lysine reactivity assay the test item showed 6.5% SPCL depletion. However, after incubation precipitation of the test item was observed. Consequently, SPCL depletion may be underestimated. Since no DPRA prediction and reactivity classification can be made based on SPCL data alone, the DPRA results obtained for test item are inconclusive.
In the cysteine reactivity assay the test item clearly co-eluted with SPCC and calculation of the peptide depletion was not possible. In the lysine reactivity assay the test item showed 6.5% SPCL depletion. However, after incubation precipitation of the test item was observed. Consequently, SPCL depletion may be underestimated. Since no DPRA prediction and reactivity classification can be made based on SPCL data alone, the DPRA results obtained for test item are inconclusive.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.